The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Models Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cell Line-derived Xenograft (CDX) Tumor Models
1.2.3 Patient-derived Xenograft (PDX) Tumor Models
1.2.4 Syngeneic Tumor Models
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tumor Models Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Trials
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Models Market Perspective (2018-2029)
2.2 Tumor Models Growth Trends by Region
2.2.1 Global Tumor Models Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tumor Models Historic Market Size by Region (2018-2023)
2.2.3 Tumor Models Forecasted Market Size by Region (2024-2029)
2.3 Tumor Models Market Dynamics
2.3.1 Tumor Models Industry Trends
2.3.2 Tumor Models Market Drivers
2.3.3 Tumor Models Market Challenges
2.3.4 Tumor Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Models Players by Revenue
3.1.1 Global Top Tumor Models Players by Revenue (2018-2023)
3.1.2 Global Tumor Models Revenue Market Share by Players (2018-2023)
3.2 Global Tumor Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Models Revenue
3.4 Global Tumor Models Market Concentration Ratio
3.4.1 Global Tumor Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Models Revenue in 2022
3.5 Tumor Models Key Players Head office and Area Served
3.6 Key Players Tumor Models Product Solution and Service
3.7 Date of Enter into Tumor Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Models Breakdown Data by Type
4.1 Global Tumor Models Historic Market Size by Type (2018-2023)
4.2 Global Tumor Models Forecasted Market Size by Type (2024-2029)
5 Tumor Models Breakdown Data by Application
5.1 Global Tumor Models Historic Market Size by Application (2018-2023)
5.2 Global Tumor Models Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tumor Models Market Size (2018-2029)
6.2 North America Tumor Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tumor Models Market Size by Country (2018-2023)
6.4 North America Tumor Models Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Models Market Size (2018-2029)
7.2 Europe Tumor Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tumor Models Market Size by Country (2018-2023)
7.4 Europe Tumor Models Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Models Market Size (2018-2029)
8.2 Asia-Pacific Tumor Models Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tumor Models Market Size by Region (2018-2023)
8.4 Asia-Pacific Tumor Models Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Models Market Size (2018-2029)
9.2 Latin America Tumor Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tumor Models Market Size by Country (2018-2023)
9.4 Latin America Tumor Models Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Models Market Size (2018-2029)
10.2 Middle East & Africa Tumor Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tumor Models Market Size by Country (2018-2023)
10.4 Middle East & Africa Tumor Models Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Inotiv
11.1.1 Inotiv Company Detail
11.1.2 Inotiv Business Overview
11.1.3 Inotiv Tumor Models Introduction
11.1.4 Inotiv Revenue in Tumor Models Business (2018-2023)
11.1.5 Inotiv Recent Development
11.2 Charles River
11.2.1 Charles River Company Detail
11.2.2 Charles River Business Overview
11.2.3 Charles River Tumor Models Introduction
11.2.4 Charles River Revenue in Tumor Models Business (2018-2023)
11.2.5 Charles River Recent Development
11.3 WuXi Biology
11.3.1 WuXi Biology Company Detail
11.3.2 WuXi Biology Business Overview
11.3.3 WuXi Biology Tumor Models Introduction
11.3.4 WuXi Biology Revenue in Tumor Models Business (2018-2023)
11.3.5 WuXi Biology Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Detail
11.4.2 Labcorp Business Overview
11.4.3 Labcorp Tumor Models Introduction
11.4.4 Labcorp Revenue in Tumor Models Business (2018-2023)
11.4.5 Labcorp Recent Development
11.5 IITRI
11.5.1 IITRI Company Detail
11.5.2 IITRI Business Overview
11.5.3 IITRI Tumor Models Introduction
11.5.4 IITRI Revenue in Tumor Models Business (2018-2023)
11.5.5 IITRI Recent Development
11.6 InSphero
11.6.1 InSphero Company Detail
11.6.2 InSphero Business Overview
11.6.3 InSphero Tumor Models Introduction
11.6.4 InSphero Revenue in Tumor Models Business (2018-2023)
11.6.5 InSphero Recent Development
11.7 Biomodels
11.7.1 Biomodels Company Detail
11.7.2 Biomodels Business Overview
11.7.3 Biomodels Tumor Models Introduction
11.7.4 Biomodels Revenue in Tumor Models Business (2018-2023)
11.7.5 Biomodels Recent Development
11.8 Reaction Biology
11.8.1 Reaction Biology Company Detail
11.8.2 Reaction Biology Business Overview
11.8.3 Reaction Biology Tumor Models Introduction
11.8.4 Reaction Biology Revenue in Tumor Models Business (2018-2023)
11.8.5 Reaction Biology Recent Development
11.9 Oncodesign Services
11.9.1 Oncodesign Services Company Detail
11.9.2 Oncodesign Services Business Overview
11.9.3 Oncodesign Services Tumor Models Introduction
11.9.4 Oncodesign Services Revenue in Tumor Models Business (2018-2023)
11.9.5 Oncodesign Services Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Detail
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Tumor Models Introduction
11.10.4 Creative Biolabs Revenue in Tumor Models Business (2018-2023)
11.10.5 Creative Biolabs Recent Development
11.11 Abnova
11.11.1 Abnova Company Detail
11.11.2 Abnova Business Overview
11.11.3 Abnova Tumor Models Introduction
11.11.4 Abnova Revenue in Tumor Models Business (2018-2023)
11.11.5 Abnova Recent Development
11.12 Invivocue
11.12.1 Invivocue Company Detail
11.12.2 Invivocue Business Overview
11.12.3 Invivocue Tumor Models Introduction
11.12.4 Invivocue Revenue in Tumor Models Business (2018-2023)
11.12.5 Invivocue Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details